Development and application of a toolkit for community pharmacist‐led review of patients with diabetes

Abstract Introduction Accessibility of community pharmacists puts them in a strategic position to support and empower patients in managing and reducing risks associated with diabetes mellitus. Objectives To develop and validate a toolkit for community pharmacist‐led review of patients with diabetes, apply the toolkit, and evaluate pharmacist interventions. Methods A toolkit for community pharmacists to use to review patients with diabetes was developed and validated. Sixty patients registered with a community pharmacy taking at least one antidiabetic medication were invited to participate in the study. At baseline (t0), the toolkit was used to compile chronic and non‐prescription medications before the first session (t1) with the patient. During t1, the toolkit was used to assess diabetes knowledge, drug therapy, medication adherence, diabetic complications, lifestyle, laboratory investigations, and monitoring. Education and drug‐related needs that were identified were documented. An intervention was proposed for each identified need, and patient follow‐up was conducted after 1 month (t2) to assess if the needs were met. Results From the 60 patients invited to the study, 55 patients completed the study. Needs were identified in 50 patients. Education‐related needs were identified in 50 patients and drug‐related needs in 18 patients. Education needs were related to medication use, storage, and therapy adherence ( n = 28), lifestyle modifications ( n = 26), and self‐monitoring ( n = 23). Drug‐related needs involved inappropriate drug selection ( n = 10), dose selection ( n = 9), and medicine handling by the patient ( n = 6). Referral to a general practitioner was required for nine patients. At t2, 65% of the identified needs were addressed. The implementation rate was highest with respect to appropriateness in dose selection (89%), followed by patient medication handling (83%). Conclusion This research has led to a practical toolkit to be used by community pharmacists for a structured review of patients with diabetes within a collaborative practice approach. The toolkit targets the identification of patient needs. A limitation of the study was patient self‐reporting.

Authors

Institutions

Publication Details

Journal
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Published
2025-03-17
DOI
https://doi.org/10.1002/jac5.70022
Citations
2
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
2.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and application of a toolkit for community pharmacist‐led review of patients with diabetes

Francesca Wirth, Lilian M. Azzopardi, Justine Borg
2 citations
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Pharmaceutical Practices and Patient Outcomes
2.45
article

Development and application of a toolkit for community pharmacist‐led review of patients with diabetes

Francesca Wirth, Lilian M. Azzopardi, Justine Borg
article en
2 citations

Abstract

Abstract Introduction Accessibility of community pharmacists puts them in a strategic position to support and empower patients in managing and reducing risks associated with diabetes mellitus. Objectives To develop and validate a toolkit for community pharmacist‐led review of patients with diabetes, apply the toolkit, and evaluate pharmacist interventions. Methods A toolkit for community pharmacists to use to review patients with diabetes was developed and validated. Sixty patients registered with a community pharmacy taking at least one antidiabetic medication were invited to participate in the study. At baseline (t0), the toolkit was used to compile chronic and non‐prescription medications before the first session (t1) with the patient. During t1, the toolkit was used to assess diabetes knowledge, drug therapy, medication adherence, diabetic complications, lifestyle, laboratory investigations, and monitoring. Education and drug‐related needs that were identified were documented. An intervention was proposed for each identified need, and patient follow‐up was conducted after 1 month (t2) to assess if the needs were met. Results From the 60 patients invited to the study, 55 patients completed the study. Needs were identified in 50 patients. Education‐related needs were identified in 50 patients and drug‐related needs in 18 patients. Education needs were related to medication use, storage, and therapy adherence ( n = 28), lifestyle modifications ( n = 26), and self‐monitoring ( n = 23). Drug‐related needs involved inappropriate drug selection ( n = 10), dose selection ( n = 9), and medicine handling by the patient ( n = 6). Referral to a general practitioner was required for nine patients. At t2, 65% of the identified needs were addressed. The implementation rate was highest with respect to appropriateness in dose selection (89%), followed by patient medication handling (83%). Conclusion This research has led to a practical toolkit to be used by community pharmacists for a structured review of patients with diabetes within a collaborative practice approach. The toolkit targets the identification of patient needs. A limitation of the study was patient self‐reporting.

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYVol. 8(6)
University of Malta (MT)
Openalex Percentile: Top 13%
Pharmaceutical Practices and Patient Outcomes
2.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.